199 related articles for article (PubMed ID: 26612336)
1. Comparing the measurement equivalence of EQ-5D-5L across different modes of administration.
Mulhern B; O'Gorman H; Rotherham N; Brazier J
Health Qual Life Outcomes; 2015 Nov; 13():191. PubMed ID: 26612336
[TBL] [Abstract][Full Text] [Related]
2. Cross-cultural measurement equivalence of the 5-level EQ-5D (EQ-5D-5L) in patients with type 2 diabetes mellitus in Singapore.
Wang Y; Tan NC; Tay EG; Thumboo J; Luo N
Health Qual Life Outcomes; 2015 Jul; 13():103. PubMed ID: 26179285
[TBL] [Abstract][Full Text] [Related]
3. Validity and measurement equivalence of EQ-5D-5L questionnaire among heart failure patients in Malaysia: a cohort study.
Kuan WC; Chee KH; Kasim S; Lim KK; Dujaili JA; Lee KK; Teoh SL
J Med Econ; 2024; 27(1):607-617. PubMed ID: 38557412
[TBL] [Abstract][Full Text] [Related]
4. Agreement Among Paper and Electronic Modes of the EQ-5D-5L.
Lundy JJ; Coons SJ; Flood E; Patel MJ;
Patient; 2020 Aug; 13(4):435-443. PubMed ID: 32346816
[TBL] [Abstract][Full Text] [Related]
5. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?
Feng Y; Devlin N; Herdman M
Health Qual Life Outcomes; 2015 Oct; 13():171. PubMed ID: 26489956
[TBL] [Abstract][Full Text] [Related]
6. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
[TBL] [Abstract][Full Text] [Related]
7. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
Cheung PWH; Wong CKH; Cheung JPY
Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
[TBL] [Abstract][Full Text] [Related]
8. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients.
Pattanaphesaj J; Thavorncharoensap M
Health Qual Life Outcomes; 2015 Feb; 13():14. PubMed ID: 25890017
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the EQ-5D-3L and 5L versions in low back pain patients.
Garratt AM; Furunes H; Hellum C; Solberg T; Brox JI; Storheim K; Johnsen LG
Health Qual Life Outcomes; 2021 May; 19(1):155. PubMed ID: 34049574
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the measurement properties of SF-6Dv2 and EQ-5D-5L in a Chinese population health survey.
Xie S; Wang D; Wu J; Liu C; Jiang W
Health Qual Life Outcomes; 2022 Jun; 20(1):96. PubMed ID: 35710429
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
[TBL] [Abstract][Full Text] [Related]
12. Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients.
Golicki D; Niewada M; Karlińska A; Buczek J; Kobayashi A; Janssen MF; Pickard AS
Qual Life Res; 2015 Jun; 24(6):1555-63. PubMed ID: 25425288
[TBL] [Abstract][Full Text] [Related]
13. An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D.
Feng Y; Herdman M; van Nooten F; Cleeland C; Parkin D; Ikeda S; Igarashi A; Devlin NJ
Qual Life Res; 2017 Aug; 26(8):2067-2078. PubMed ID: 28343350
[TBL] [Abstract][Full Text] [Related]
14. Danish population health measured by the EQ-5D-5L.
Jensen MB; Jensen CE; Gudex C; Pedersen KM; Sørensen SS; Ehlers LH
Scand J Public Health; 2023 Mar; 51(2):241-249. PubMed ID: 34847818
[TBL] [Abstract][Full Text] [Related]
15. Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey.
Jankowska A; Młyńczak K; Golicki D
Health Qual Life Outcomes; 2021 May; 19(1):138. PubMed ID: 33952271
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the scaling properties of the English, Spanish, French, and Chinese EQ-5D descriptive systems.
Luo N; Li M; Chevalier J; Lloyd A; Herdman M
Qual Life Res; 2013 Oct; 22(8):2237-43. PubMed ID: 23266797
[TBL] [Abstract][Full Text] [Related]
17. Healthcare consumer acceptability of routine use of the EQ-5D-5L in clinical care: a cross-sectional survey.
Snowdon DA; Collyer TA; Marsh L; Srikanth V; Beare R; Baber S; Naude K; Andrew NE
Qual Life Res; 2024 May; 33(5):1307-1321. PubMed ID: 38321194
[TBL] [Abstract][Full Text] [Related]
18. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
[TBL] [Abstract][Full Text] [Related]
19. Validation of Brunei's Malay EQ-5D Questionnaire in Patients with Type 2 Diabetes.
Koh D; Abdullah AM; Wang P; Lin N; Luo N
PLoS One; 2016; 11(11):e0165555. PubMed ID: 27835652
[TBL] [Abstract][Full Text] [Related]
20. Reliability of the quality of life-aged care consumers (QOL-ACC) and EQ-5D-5L among older people using aged care services at home.
Khadka J; Milte R; Hutchinson C; Cleland J; Ratcliffe J
Health Qual Life Outcomes; 2024 May; 22(1):40. PubMed ID: 38816717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]